According to RVL Pharmaceuticals's latest financial reports the company's current earnings (TTM) are -S$89.28 M. In 2022 the company made an earning of -S$67.36 M an increase over its 2021 earnings that were of -S$99.98 M.The earnings displayed on this page is the company's Pretax Income.